Patent ID: 8367677

Claim:
A pharmaceutical composition comprising at least one compound of formula (C) or (D) and a pharmaceutically acceptable carrier which is useful in a medicine wherein —X′ is m is 0 or 1; Y′ is Q is CH or N; K is S or O; v is 0, 1, or 2; R 6 is CO 2 H, CO 2 Alkyl, CO 2 Aryl, CO 2 NH 2 , CO 2 Aralkyl, SO 3 H, SO 2 NH 2 , PO(OH) 2 , 1-H-tetrazolyl, CHO, COCH 3 , CH 2 OH, NH 2 , NHAlkyl, N(Alkyl)Alkyl′, OCH 3 , CH 2 OCH 3 , SH, F, Cl, Br, I, CH 3 , CH 2 CH 3 , CN, or CF 3 ; R 7 , independently from R 6 , is H, CH 3 , CH 2 CH 3 , CF 3 , F, Cl, Br, I, CN, or NO 2 ; R 8 , independently from R 6 and R 7 , is H, CH 3 , CH 2 CH 3 , CF 3 , F, Cl, Br, I, CN, NO 2 , or R 6 ; R 9a is H, NO 2 , CF 3 , F, Cl, Br, I, CN, CH 3 , OCH 3 , SH, or NH 2 ; R 9b , independently from R 9a , is H, NO 2 , CF 3 , F, Cl, Br, I, CN, CH 3 , OCH 3 , SH, or NH 2 ; R 10 is CO 2 H, CO 2 alkyl, CO 2 aryl, CO 2 NH 2 , CO 2 aralkyl, CH 2 SO 3 H, CH 2 SO 2 NH 2 , CH 2 PO(OH) 2 , 1-H-tetrazolyl, CHO, COCH 3 , CH 2 OH, CH 2 NH 2 , CH 2 NHalkyl, CH 2 N(alkyl)alkyl′, CH 2 OCH 3 , or CH 2 SH; R 11 is CO 2 H, CO 2 alkyl, CO 2 aryl, CO 2 NH 2 , CO 2 aralkyl, SO 3 H, SO 2 NH 2 , PO(OH) 2 , 1-H-tetrazolyl, CHO, COCH 3 , OH, NH 2 , NHalkyl, N(alkyl)alkyl′, OCH 3 , or SH; s is 1; t is 0, 1, or 2; —W— is —(CH 2 —) v , cis-CH═CH— or trans-CH═CH—, and v is 0, 1, or 2; in case that R 6 is NH 2 , R 7 or R 8 or R 9a must not be H; and in case that —W— is cis-CH═CH— or trans-CH═CH—, R 6 must not be NH 2 or SH; or the pharmaceutically acceptable salts, esters, or amides of the compounds of formula (C) or (D).